Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy

Background: One of the leading causes of terminal renal failure is diabetic nephropathy. The aim of this study was to determine the relationship between homocysteine levels and the biomarkers of renal function, inflammation and oxidative stress, as well as the incidence of macrovascular complication...

Full description

Bibliographic Details
Main Authors: Čabarkapa Velibor, Đerić Mirjana, Stošić Zoran, Sakač Vladimir, Davidović Sofija, Eremić Nevena
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2013-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2013/1452-82581302131C.pdf
_version_ 1818434331700363264
author Čabarkapa Velibor
Đerić Mirjana
Stošić Zoran
Sakač Vladimir
Davidović Sofija
Eremić Nevena
author_facet Čabarkapa Velibor
Đerić Mirjana
Stošić Zoran
Sakač Vladimir
Davidović Sofija
Eremić Nevena
author_sort Čabarkapa Velibor
collection DOAJ
description Background: One of the leading causes of terminal renal failure is diabetic nephropathy. The aim of this study was to determine the relationship between homocysteine levels and the biomarkers of renal function, inflammation and oxidative stress, as well as the incidence of macrovascular complications in patients with diabetic nephropathy. Methods: Sixty-four patients with diabetic nephropathy were included in this study. They were divided according to their homocysteine levels into two groups: hyperhomocysteinemic (HHcy, n=47) and normohomocysteinemic patients (NHCy, n=17). The results were compared to a control group (n=20) with normal renal function and without diabetes. Besides homocysteine, cystatine C, creatinine, urea, albuminuria, creatinine clearance, lipid status parameters, apolipoprotein A-I and B, lipoprotein (a), CRP, fibrinogen, oxidative LDL were determined using appropriate methods. The incidence of macro vascular diabetic complications was also determined. Results: The results indicate that the level of renal dysfunction is greater in HHcy than in NHcy patients (p<0.05). In HHcy patients levels of oxLDL were also higher compared to NHcy patients (119.3±140.4 vs. 71.4±50.8 ng/mL, disp< 0.05) as well as fibrinogen levels (4.3±1.3 vs. 3.7±0.8 g/L, p<0.05). The incidence of macrovascular complications is more frequent in HHcy than in NHcy patients (55.3. vs. 35.3 %, p>0.05), and in patients with macroalbuminuria compared to patients with microalbuminuria (65% vs. 39%, p<0.05). Conclusions: It can be concluded that HHcy is significantly present in patients with diabetic nephropathy, especially if there is greater reduction of renal function. Besides that, significantly higher concentrations of inflammatory (fibrinogen) and oxidative stress (oxLDL) markers were present in HHcy patients with diabetic nephropathy compared to NHcy patients. Therefore in diabetic nephropathy patients it is useful to regularly monitor the levels of homocysteine, as well as inflammatory and markers of oxidative stress.
first_indexed 2024-12-14T16:35:18Z
format Article
id doaj.art-6d6b184126e94907a962b3ee68bbc1ee
institution Directory Open Access Journal
issn 1452-8258
1452-8266
language English
last_indexed 2024-12-14T16:35:18Z
publishDate 2013-01-01
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format Article
series Journal of Medical Biochemistry
spelling doaj.art-6d6b184126e94907a962b3ee68bbc1ee2022-12-21T22:54:28ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662013-01-013221311391452-82581302131CDetermining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathyČabarkapa Velibor0https://orcid.org/0000-0001-7166-3379Đerić Mirjana1Stošić Zoran2Sakač Vladimir3Davidović Sofija4Eremić Nevena5Center for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadClinic for Nephrology and Clinical Immunology, Clinical Center of Vojvodina, Novi SadUniversity Eye Clinic, Medical Faculty, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadBackground: One of the leading causes of terminal renal failure is diabetic nephropathy. The aim of this study was to determine the relationship between homocysteine levels and the biomarkers of renal function, inflammation and oxidative stress, as well as the incidence of macrovascular complications in patients with diabetic nephropathy. Methods: Sixty-four patients with diabetic nephropathy were included in this study. They were divided according to their homocysteine levels into two groups: hyperhomocysteinemic (HHcy, n=47) and normohomocysteinemic patients (NHCy, n=17). The results were compared to a control group (n=20) with normal renal function and without diabetes. Besides homocysteine, cystatine C, creatinine, urea, albuminuria, creatinine clearance, lipid status parameters, apolipoprotein A-I and B, lipoprotein (a), CRP, fibrinogen, oxidative LDL were determined using appropriate methods. The incidence of macro vascular diabetic complications was also determined. Results: The results indicate that the level of renal dysfunction is greater in HHcy than in NHcy patients (p<0.05). In HHcy patients levels of oxLDL were also higher compared to NHcy patients (119.3±140.4 vs. 71.4±50.8 ng/mL, disp< 0.05) as well as fibrinogen levels (4.3±1.3 vs. 3.7±0.8 g/L, p<0.05). The incidence of macrovascular complications is more frequent in HHcy than in NHcy patients (55.3. vs. 35.3 %, p>0.05), and in patients with macroalbuminuria compared to patients with microalbuminuria (65% vs. 39%, p<0.05). Conclusions: It can be concluded that HHcy is significantly present in patients with diabetic nephropathy, especially if there is greater reduction of renal function. Besides that, significantly higher concentrations of inflammatory (fibrinogen) and oxidative stress (oxLDL) markers were present in HHcy patients with diabetic nephropathy compared to NHcy patients. Therefore in diabetic nephropathy patients it is useful to regularly monitor the levels of homocysteine, as well as inflammatory and markers of oxidative stress.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2013/1452-82581302131C.pdfhomocysteinebiomarkersdiabetic nephropathy
spellingShingle Čabarkapa Velibor
Đerić Mirjana
Stošić Zoran
Sakač Vladimir
Davidović Sofija
Eremić Nevena
Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
Journal of Medical Biochemistry
homocysteine
biomarkers
diabetic nephropathy
title Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
title_full Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
title_fullStr Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
title_full_unstemmed Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
title_short Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
title_sort determining the relationship between homocysteinemia and biomarkers of inflammation oxidative stress and functional kidney status in patients with diabetic nephropathy
topic homocysteine
biomarkers
diabetic nephropathy
url https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2013/1452-82581302131C.pdf
work_keys_str_mv AT cabarkapavelibor determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy
AT đericmirjana determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy
AT stosiczoran determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy
AT sakacvladimir determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy
AT davidovicsofija determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy
AT eremicnevena determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy